Sage Rhino Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,957
Closed -$320K – 226
2023
Q2
$320K Sell
3,957
-346
-8% -$32.4K 0.09% 152
2023
Q1
$523K Sell
4,303
-244
-5% -$33.1K 0.15% 111
2022
Q4
$605K Buy
4,547
+196
+5% +$23.8K 0.19% 100
2022
Q3
$486K Buy
4,351
+61
+1% +$7.8K 0.2% 91
2022
Q2
$582K Sell
4,290
-164
-4% -$24.7K 0.22% 83
2022
Q1
$742K Sell
4,454
-517
-10% -$98.2K 0.23% 81
2021
Q4
$888K Buy
4,971
+3
+0.1% +$535 0.25% 76
2021
Q3
$879K Buy
4,968
+53
+1% +$8.78K 0.27% 64
2021
Q2
$790K Buy
4,915
+338
+7% +$52K 0.23% 76
2021
Q1
$685K Buy
+4,577
New +$555K 0.23% 80

Other funds holding CNXC

Sage Rhino Capital's CNXC Position: Q3 2023 in Review

Sage Rhino Capital sold out of Concentrix (CNXC) in Q3 2023, closing a stake of 3,957 shares — an estimated $320K sold.

Sage Rhino Capital first reported a position in CNXC in Q1 2021 and held it in 10 quarters. The position peaked at $888K in Q4 2021. 301 funds tracked by Wall St. Rank hold CNXC as of Q3 2023.

  • Sage Rhino Capital reported no remaining Concentrix position as of Q3 2023 after selling out during the quarter.
  • Sage Rhino Capital sold 3,957 Concentrix shares in Q3 2023, an estimated $320K.
  • Sage Rhino Capital first reported a position in Concentrix in Q1 2021 and held it in 10 quarters.
  • Sage Rhino Capital's Concentrix position peaked at $888K in Q4 2021.
  • 301 funds tracked by Wall St. Rank held Concentrix as of Q3 2023.

Based on Sage Rhino Capital's 13F filing for Q3 2023, filed 26 Oct 2023.